Keyphrases
Pulmonary Hypertension
100%
Cyclic Guanosine Monophosphate Signaling
100%
Bronchopulmonary Dysplasia
83%
Room Air
83%
Phosphodiesterase Type 5 Inhibitors
50%
Pulmonary Artery
50%
Sildenafil
50%
Vessel Density
50%
Air Recovery
50%
Hyperoxia
33%
Alveolar Simplification
33%
Medial Wall
33%
Wall Thickness
33%
Preterm Birth
16%
Common Complications
16%
Signaling Pathway
16%
Cyclic GMP
16%
Neonatal Mice
16%
Lung Disease
16%
C57BL
16%
Moderate to Severe
16%
Hyperoxia Exposure
16%
Soluble Guanylate Cyclase
16%
Pulmonary Vascular Remodeling
16%
Natural History
16%
Little Data
16%
Treatment Delay
16%
Neonatal Hyperoxia
16%
Medicine and Dentistry
Pulmonary Hypertension
100%
Cyclic GMP
100%
Lung Dysplasia
83%
Pulmonary Artery
66%
Phosphodiesterase V
50%
Hyperoxia
50%
Sildenafil
50%
C57BL/6
16%
Premature Labor
16%
Silo-Filler's Disease
16%
Clinical Study
16%
Cell Signaling Pathway
16%
Guanylate Cyclase
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclic GMP
100%
Pulmonary Hypertension
100%
Lung Dysplasia
83%
Sildenafil
50%
Phosphodiesterase V
50%
Clinical Study
16%
C57BL 6 Mouse
16%
Lung Disease
16%
Premature Labor
16%
Guanylate Cyclase
16%
Diseases
16%